BusinessStartups

Core Scientific Stock Upgraded as Standalone Prospects Outweigh Acquisition Hopes

Investment firm Roth Capital Partners has upgraded Core Scientific to buy despite fading acquisition prospects. Analysts suggest the company’s standalone value lies in leasing its substantial power capacity for high-performance computing applications.

Analyst Upgrade Amid Shifting Acquisition Landscape

Roth Capital Partners has reportedly upgraded Core Scientific shares from neutral to buy, according to recent analyst reports, even as the potential acquisition by CoreWeave appears less likely. Analyst Darren Aftahi simultaneously raised his 12-month price target to $23.50 from $17, suggesting a potential 32% gain based on the company’s standalone prospects.

Arts and EntertainmentSemiconductors

TSMC Boosts Annual Revenue Forecast as AI Chip Demand Defies Trade Headwinds

Taiwan Semiconductor Manufacturing Co. has reportedly increased its annual revenue growth projection to mid-30% as third-quarter profits reached record levels. The upward revision comes despite ongoing trade tensions and U.S. tariff pressures affecting the global semiconductor industry.

Record Profits Drive Optimistic Outlook

Taiwan Semiconductor Manufacturing Co. (TSMC) has further elevated its revenue guidance for the year as the company’s third-quarter profits soared to unprecedented levels, according to recent reports. Sources indicate the world’s largest contract chip maker now anticipates mid-30% revenue growth for the year, up from its previous projection of approximately 30% growth.